Phibro Animal Health (PAHC) to Release Quarterly Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is expected to release its earnings data after the market closes on Wednesday, February 5th. Analysts expect Phibro Animal Health to post earnings of $0.40 per share and revenue of $292.26 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.340-1.480 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.12. The business had revenue of $260.40 million for the quarter, compared to analysts’ expectations of $277.76 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. During the same period last year, the firm posted $0.14 earnings per share. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Trading Down 1.3 %

Phibro Animal Health stock opened at $21.99 on Wednesday. The business has a 50-day simple moving average of $22.08 and a two-hundred day simple moving average of $21.48. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company has a market cap of $890.60 million, a P/E ratio of 51.14, a P/E/G ratio of 0.56 and a beta of 0.53.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.18%. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Analyst Upgrades and Downgrades

PAHC has been the subject of several analyst reports. Morgan Stanley upped their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, January 12th. Finally, Barclays raised their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.